Dose uniformity of topical corticosteroid preparations: Difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%

Clinical Ophthalmology

Volumn 4, Issue 1, 2010, Pages 1119-1124

  Stringer, William ^a   Bryant, Roy ^b  

^a Module 3 Pharma Services   (United States)

^b Encompass Pharmaceutical Services   (United States)

Author keywords

Difluprednate; Dose uniformity; Emulsion; Prednisolone acetate

Indexed keywords

CORTICOSTEROID; DIFLUPREDNATE; GENERIC DRUG; PREDNISOLONE ACETATE;

ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG STORAGE; DRUG USE; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PREDICTION; SIMULATION; SUSPENSION;

EID: 78650690326     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S12441     Document Type: Article

References (8)

1. Diestelhorst M, Kwon KA, Suverkrup R. Dose uniformity of ophthalmic suspensions. J Cataract Refract Surg. 1998;24(5):672-677.
2. Deicke A, Suverkrup R. Dose uniformity and redispersibility of pharmaceutical suspensions. I: Quantification and mechanical modelling of human shaking behaviour. Eur J Pharm Biopharm. 1999;48(3): 225-232.
3. Apt L, Henrick A, Silverman LM. Patient compliance with use of topical ophthalmic corticosteroid suspensions. Am J Ophthalmol. 1979; 87(2):210-214.
4. Durezol® [Package insert]. Tampa FL. Sirion Therapuetics, Inc.; 2008.
5. Pred Forte® [Package insert]. Irvine CA. Allergan, Inc.; 2004.
6. Jamal KN, Callanan DG. The role of difluprednate ophthalmic emulsion in clinical practice. Clin Ophthalmol. 2009;3:381-390.
7. Yamaguchi M, Yasueda S, Isowaki A, et al. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Int J Pharm. 2005;301(1-2):121-128.
8. Inoue J, Yamaguchi M, Sakaki H, et al. Preclinical pharmacokinetics of difluprednate ophthalmic emulsion. 2007 Annual Meeting of the Association for Research in Vision and Ophthalmology. Poster 2651. Fort Lauderdale, Florida, USA, 2007 May 6-10.